191 related articles for article (PubMed ID: 30335701)
1. Liver Transplantation Trends and Outcomes for Hereditary Hemorrhagic Telangiectasia in the United States.
Iyer VN; Saberi B; Heimbach JK; Larson JJ; Raghavaiah S; Ditah I; Swanson K; Kamath PS; Watt KD; Taner T; Krowka MJ; Leise MD
Transplantation; 2019 Jul; 103(7):1418-1424. PubMed ID: 30335701
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study.
Dupuis-Girod S; Chesnais AL; Ginon I; Dumortier J; Saurin JC; Finet G; Decullier E; Marion D; Plauchu H; Boillot O
Liver Transpl; 2010 Mar; 16(3):340-7. PubMed ID: 20209594
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry.
Lerut J; Orlando G; Adam R; Sabbà C; Pfitzmann R; Klempnauer J; Belghiti J; Pirenne J; Thevenot T; Hillert C; Brown CM; Gonze D; Karam V; Boillot O;
Ann Surg; 2006 Dec; 244(6):854-62; discussion 862-4. PubMed ID: 17122610
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation for hereditary hemorrhagic telangiectasia: a systematic review.
Felli E; Addeo P; Faitot F; Nappo G; Oncioiu C; Bachellier P
HPB (Oxford); 2017 Jul; 19(7):567-572. PubMed ID: 28427830
[TBL] [Abstract][Full Text] [Related]
5. Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.
Rifai G; Anani A; Hanouneh IA; Mohamad B; Matloob A; Lopez R; Zein NN; Alkhouri N
Transplant Proc; 2016 Dec; 48(10):3362-3367. PubMed ID: 27931582
[TBL] [Abstract][Full Text] [Related]
6. Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States.
Campos-Varela I; Dodge JL; Berenguer M; Adam R; Samuel D; Di Benedetto F; Karam V; Belli LS; Duvoux C; Terrault NA
Transplantation; 2020 Oct; 104(10):2078-2086. PubMed ID: 32969987
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of Hereditary Hemorrhagic Telangiectasia After Liver Transplantation: Clinical Implications and Physiopathological Insights.
Dumortier J; Dupuis-Girod S; Valette PJ; Valent A; Guillaud O; Saurin JC; Hervieu V; Robinson P; Plauchu H; Paliard P; Boillot O; Scoazec JY
Hepatology; 2019 May; 69(5):2232-2240. PubMed ID: 30549294
[TBL] [Abstract][Full Text] [Related]
8. Hereditary hemorrhagic telangiectasia, liver vascular malformations and cardiac consequences.
Ginon I; Decullier E; Finet G; Cordier JF; Marion D; Saurin JC; Dupuis-Girod S
Eur J Intern Med; 2013 Apr; 24(3):e35-9. PubMed ID: 23312966
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.
Mitchell A; Adams LA; MacQuillan G; Tibballs J; vanden Driesen R; Delriviere L
Liver Transpl; 2008 Feb; 14(2):210-3. PubMed ID: 18236396
[TBL] [Abstract][Full Text] [Related]
10. Hereditary haemorrhagic telangiectasia: to transplant or not to transplant - is there a right time for liver transplantation?
Muller YD; Oppliger R; Breguet R; Meyer P; Rubbia-Brandt L; Petignat PA; Harr T; Dayer E; Seebach JD
Liver Int; 2016 Dec; 36(12):1735-1740. PubMed ID: 27864873
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.
Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831
[TBL] [Abstract][Full Text] [Related]
12. Surgical Treatment vs Nonsurgical Treatment for Brain Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia: A Retrospective Multicenter Consortium Study.
Meybodi AT; Kim H; Nelson J; Hetts SW; Krings T; terBrugge KG; Faughnan ME; Lawton MT;
Neurosurgery; 2018 Jan; 82(1):35-47. PubMed ID: 28973426
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.
Dupuis-Girod S; Ginon I; Saurin JC; Marion D; Guillot E; Decullier E; Roux A; Carette MF; Gilbert-Dussardier B; Hatron PY; Lacombe P; Lorcerie B; Rivière S; Corre R; Giraud S; Bailly S; Paintaud G; Ternant D; Valette PJ; Plauchu H; Faure F
JAMA; 2012 Mar; 307(9):948-55. PubMed ID: 22396517
[TBL] [Abstract][Full Text] [Related]
14. Subaortic Membranes in Patients With Hereditary Hemorrhagic Telangiectasia and Liver Vascular Malformations.
Kim AS; Henderson KJ; Pawar S; Kim MJ; Punjani S; Pollak JS; Fahey JT; Garcia-Tsao G; Sugeng L; Young LH
J Am Heart Assoc; 2020 Oct; 9(20):e016197. PubMed ID: 33054561
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward.
Krowka MJ; Wiesner RH; Heimbach JK
J Hepatol; 2013 Aug; 59(2):367-74. PubMed ID: 23557870
[TBL] [Abstract][Full Text] [Related]
16. The outcomes of adult liver transplants in the United States from 1987 to 2013.
Stepanova M; Wai H; Saab S; Mishra A; Venkatesan C; Younossi ZM
Liver Int; 2015 Aug; 35(8):2036-41. PubMed ID: 25559873
[TBL] [Abstract][Full Text] [Related]
17. Liver transplantation for hepatic arteriovenous malformation with high-output cardiac failure in hereditary hemorrhagic telangiectasia: hemodynamic study.
Le Corre F; Golkar B; Tessier C; Kavafyan J; Marty J
J Clin Anesth; 2000 Jun; 12(4):339-42. PubMed ID: 10960210
[TBL] [Abstract][Full Text] [Related]
18. The role of liver transplantation in the treatment of hereditary hemorrhagic telangiectasia: a short literature review.
Scelzo C; Greco S; Bonanni L; Di Cocco P; D'Angelo M; Laurenzi C; Pisani F; Famulari A; Orlando G
Transplant Proc; 2007; 39(6):2045-7. PubMed ID: 17692689
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Anastomotic Biliary Complications in Adult Patients Undergoing High-Acuity Liver Transplant.
Kaldas FM; Korayem IM; Russell TA; Agopian VG; Aziz A; DiNorcia J; Farmer DG; Yersiz H; Hiatt JR; Busuttil RW
JAMA Surg; 2019 May; 154(5):431-439. PubMed ID: 30758485
[TBL] [Abstract][Full Text] [Related]
20. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
